Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nussbaum

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Journal of Surgical Oncology|September 6, 2023
Tumor size and survival in intrahepatic cholangiocarcinoma treated with surgical resection or ablationElishama N Kanu, Kristen E Rhodin, Sabran J Masoud, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 4, 2024
Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinomaThomas Clark Howell, Kristen E Rhodin, Brian Shaw, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2025
A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolutionElishama N Kanu, Ashley A Fletcher, Jiayin Bao, et al.
Annals of Surgical Oncology|July 12, 2023
Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic CholangiocarcinomaSabran J Masoud, Kristen E Rhodin, Elishama Kanu, et al.
Science Translational Medicine|December 16, 2016
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translationGray R Anderson, Suzanne E Wardell, Merve Cakir, et al.
Cell Reports|July 27, 2017
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R Anderson, Peter S Winter, Kevin H Lin, et al.
NPJ Precision Oncology|May 31, 2024
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancersDaniel P Nussbaum, Colin A Martz, Andrew M Waters, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2025
Histologic- and Genomic-Directed Adjuvant Therapy for Ampullary Adenocarcinoma: A Hidden Genome-Derived AnalysisBrett L Ecker, Kenneth Seier, Ankur Choubey, et al.
JAMA Surgery|September 11, 2024
Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection PrognosticationBrett L Ecker, Kenneth Seier, Austin M Eckhoff, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Hierarchical classification of immune cell transcriptomes at population-scaleChristopher Beltz, Zekai Qiu, Leon Sadowski, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Journal of Surgical Oncology|September 6, 2023
Tumor size and survival in intrahepatic cholangiocarcinoma treated with surgical resection or ablationElishama N Kanu, Kristen E Rhodin, Sabran J Masoud, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 4, 2024
Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinomaThomas Clark Howell, Kristen E Rhodin, Brian Shaw, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2025
A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolutionElishama N Kanu, Ashley A Fletcher, Jiayin Bao, et al.
Annals of Surgical Oncology|July 12, 2023
Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic CholangiocarcinomaSabran J Masoud, Kristen E Rhodin, Elishama Kanu, et al.
Science Translational Medicine|December 16, 2016
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translationGray R Anderson, Suzanne E Wardell, Merve Cakir, et al.
Cell Reports|July 27, 2017
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R Anderson, Peter S Winter, Kevin H Lin, et al.
NPJ Precision Oncology|May 31, 2024
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancersDaniel P Nussbaum, Colin A Martz, Andrew M Waters, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2025
Histologic- and Genomic-Directed Adjuvant Therapy for Ampullary Adenocarcinoma: A Hidden Genome-Derived AnalysisBrett L Ecker, Kenneth Seier, Ankur Choubey, et al.
JAMA Surgery|September 11, 2024
Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection PrognosticationBrett L Ecker, Kenneth Seier, Austin M Eckhoff, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Hierarchical classification of immune cell transcriptomes at population-scaleChristopher Beltz, Zekai Qiu, Leon Sadowski, et al.
Pageof 12